Ultimately, the choice between the two will depend on factors like an individual patients needs, medical history and insurance coverage
The criteria for both Mounjaro and Wegovy are: BMI of 30 or above, or BMI of 27 or above with at least one weight-related health condition (such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea) If your BMI is below 27, you wont currently be eligible for GLP-1 medication for weight management through the NHS or private prescribers in the UK 7,8
Lo hacemos mediante innovaciones cientficas pioneras, ampliando el acceso a nuestros medicamentos y trabajando para prevenir y, en ltima instancia, curar enfermedades
Researchers studying metabolic pathways often examine the aod-9604 research peptide for its role in lipid metabolism and signaling analysis.
Nat Neurosci 2006;9(1):119-126